AERIAL Trial: Antiplatelet Therapy in Heart Transplantation

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2021
Cardiac allograft vasculopathy is a common complication affecting heart transplant patients. This condition causes narrowing of the heart arteries leading to graft dysfunction. The research team is investigating whether early antiplatelet therapy post heart transplant can prevent the development of CAV. This study will determine the feasibility of a large multicenter randomized placebo-controlled trial to answer this question.
Epistemonikos ID: bcad2f7ad37aee7602a0aaa86ad2a82d96f8f846
First added on: Dec 20, 2022